Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Physiology. Renal Physiology|January 4, 2013
PAR2-induced inflammatory responses in human kidney tubular epithelial cellsDavid A Vesey, Jacky Y Suen, Vernon Seow, et al.
Biochemical and Biophysical Research Communications|December 3, 2019
A cost-effective three-dimensional culture platform functionally mimics the adipose tissue microenvironment surrounding the kidneyKunyu Shen, David A Vesey, Sumaira Z Hasnain, et al.
International Journal of Molecular Sciences|July 24, 2021
PAR2-Induced Tissue Factor Synthesis by Primary Cultures of Human Kidney Tubular Epithelial Cells Is Modified by Glucose AvailabilityTyrone L R Humphries, Kunyu Shen, Abishek Iyer, et al.
Plos One|March 25, 2021
Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell linesChristudas Morais, Retnagowri Rajandram, Jade S Blakeney, et al.
BJU International|July 10, 2007
Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levelsCatherine W Cheung, Paul J Taylor, Carl M J Kirkpatrick, et al.
The American Journal of Pathology|July 17, 2012
Evidence for steroidogenic potential in human prostate cell lines and tissuesNigel C Bennett, John D Hooper, Duncan Lambie, et al.
Clinical and Translational Gastroenterology|August 3, 2019
Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver DiseaseAshok S Raj, Erin R Shanahan, Cuong D Tran, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2015
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat ArthritisRink-Jan Lohman, Abishek Iyer, Thomas J Fairlie, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2016
Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activityMei-Kwan Yau, Ligong Liu, Junxian Lim, et al.
Personalized Medicine|March 3, 2025
Head-to-head comparison of tyrosine kinase inhibitors in renal cell carcinoma using patient-derived cell cultureAaron J Urquhart, Christian H Glass, Tyrone L R Humphries, et al.
Pageof 10